Takeda Pharmaceutical (TAK) Goodwill & Intangibles: 2018-2025

  • Takeda Pharmaceutical's Goodwill & Intangibles fell 10.17% to $58.7 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $58.7 billion, marking a year-over-year decrease of 10.17%. This contributed to the annual value of $58.8 billion for FY2025, which is 12.45% down from last year.
  • As of Q1 2025, Takeda Pharmaceutical's Goodwill & Intangibles stood at $58.7 billion, which was down 10.17% from $65.4 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Goodwill & Intangibles high stood at $75.0 billion for Q1 2021, and its period low was $58.7 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Goodwill & Intangibles averaged around $64.2 billion, with its median value being $65.4 billion (2024).
  • Data for Takeda Pharmaceutical's Goodwill & Intangibles shows a maximum YoY declined of 10.17% (in 2025) over the last 5 years.
  • Takeda Pharmaceutical's Goodwill & Intangibles (Quarterly) stood at $75.0 billion in 2021, then declined by 5.67% to $70.8 billion in 2022, then decreased by 3.23% to $68.5 billion in 2023, then fell by 4.59% to $65.4 billion in 2024, then dropped by 10.17% to $58.7 billion in 2025.
  • Its last three reported values are $58.7 billion in Q1 2025, $65.4 billion for Q1 2024, and $68.5 billion during Q1 2023.